ABSTRACT
Purpose: This study aimed to determine the onset and duration of action of 3 commercially available topical anesthetic solutions in Brazil, using the Cochet-Bonnet esthesiometer (Luneau®, Paris, France) and to quantitatively assess patient-reported discomfort during application. Methods: A prospective, randomized, masked, and double-blind study was conducted, involving 40 eyes from 21 patients. Patients were administered each one of the topical anesthetics weekly, and corneal sensitivity was measured using the Cochet-Bonnet esthesiometer's corneal touch threshold (CTT). Patients rated the burning sensation using a visual analogue scale (VAS). Results: Among the 21 patients (42.9% male), with a mean age of 31.95 years (±standard deviation = 10.17, range = 22.0-58.0), corneal sensitivity significantly decreased 30 s after application, returning to baseline after 30 min for all groups (P < 0.0001). Significant differences in CTT were observed at 5 min, with proparacaine exhibiting a superior anesthetic effect (P = 0.0003), at 10 min, where tetracaine displayed the most substantial anesthetic effect (P = 0.0135), and at 20 min, where tetracaine demonstrated the highest anesthetic efficacy (P < 0.0001). VAS scores indicated the most intense burning sensation with tetracaine (P < 0.0001). Men reported experiencing more discomfort during instillation compared with women (P = 0.0168). Conclusions: Proparacaine exhibited the fastest onset of action among the 3 topical anesthetics and provided a more comfortable eye sensation during instillation. However, tetracaine demonstrated the longest duration of action despite causing more discomfort.
Subject(s)
Anesthetics, Local , Cornea , Procaine , Propoxycaine , Tetracaine , Humans , Male , Female , Tetracaine/administration & dosage , Tetracaine/pharmacology , Adult , Double-Blind Method , Propoxycaine/administration & dosage , Propoxycaine/pharmacology , Anesthetics, Local/administration & dosage , Anesthetics, Local/pharmacology , Middle Aged , Prospective Studies , Cornea/drug effects , Procaine/administration & dosage , Procaine/pharmacology , Procaine/analogs & derivatives , Procaine/adverse effects , Young Adult , Ophthalmic Solutions/administration & dosage , Pain Measurement/methodsABSTRACT
PURPOSE: To evaluate the clinical results of cryopreserved amniotic membrane transplantation as a treatment option for refractory neurotrophic corneal ulcers. METHODS: This prospective study included 11 eyes of 11 patients who underwent amniotic membrane transplantation for the treatment of refractory neurotrophic corneal ulcers at Hospital de Clínicas da Universidade Federal do Paraná, in the city of Curitiba, from May 2015 to July 2021. Patients underwent different surgical techniques in which the amniotic membrane was applied with the epithelium facing upward to promote corneal re-epithelialization. RESULTS: The median age of the patients was 60 years (range, 34-82 years), and 64% were men. The predominant etiology of corneal ulcers was herpes zoster (45% of cases). Approximately one-third of the patients (27%) were chronically using hypotensive eye drops, and more than half (54%) had previously undergone penetrating corneal transplantation. At the time of amniotic membrane transplantation, 18% of the eyes had corneal melting, 9% had corneal perforation, and the others had corneal ulceration without other associated complications (73%). The time between clinical diagnosis and surgical treatment ranged from 9 days to 2 years. The corrected visual acuity was worse than 20/400 in 90% of the patients preoperatively, with improvement in 36% after 3 months of the procedure, worsening in 18% and remaining stable in 36%. Of the patients, 81% complained of preoperative pain, and 66% of them reported total symptom relief after the surgical procedure. In one month, 54.6% of the patients presented a closure of epithelial defect, and half of the total group evolved with corneal thinning. The failure rate was 45.5% of the cases. CONCLUSION: Cryopreserved amniotic membrane transplantation can be considered a good alternative for treating refractory neurotrophic corneal ulcers, as it resulted in significant improvement in pain (66%) and complete epithelial closure (60%) in many patients at 1 month postoperatively. Notably, the high failure rate highlights the need for further studies to identify patientand ulcer-related factors that may influence the outcomes of this procedure.
Subject(s)
Corneal Ulcer , Keratitis , Male , Humans , Adult , Middle Aged , Aged , Aged, 80 and over , Female , Corneal Ulcer/surgery , Ulcer , Amnion , Prospective Studies , Cornea , PainABSTRACT
ABSTRACT Objective: To analyze the morphological and functional long-term outcomes of amniotic membrane transplantation after ocular surface chemical burns. Methods: This prospective study analyzed 7 patients who suffered from severe ocular surface burn and underwent amniotic membrane transplantation from 2015 to 2020 in Hospital de Clínicas - Universidade Federal do Paraná. Results: Out of the seven patients, six (85.7%) suffered unilateral burn and one (14.3%) suffered bilateral burn. Five of them had alkali burns (71.4%), one had acid burn (14.3%) and one suffered gunpowder fireworks burn (14.3%). Mean age was 29.4 years (±standard deviation 13.3, range 14.0 to 47.0 years). Mean visual acuity at first presentation was 1.83±0.79 logMAR (0.015 decimal) and mean VA after a follow-up of 1 year was 0.85±0.70 logMAR (0.141 decimal). The visual acuity significantly improved from 1.83±0.79 to 0.85±0.70 logMAR (p<0.05). Conclusion: Amniotic membrane transplantation is an effective adjunctive treatment in the management of ocular surface chemical burns with potential to improve the final vision outcome.
RESUMO Objetivo: Analisar os resultados morfológicos e funcionais a longo prazo do transplante de membrana amniótica após queimaduras químicas da superfície ocular. Métodos: Foi realizado um estudo prospectivo com análise de sete pacientes que sofreram queimaduras graves da superfície ocular e foram submetidos a transplante de membrana amniótica no período de 2015 a 2020 no Hospital de Clínicas da Universidade Federal do Paraná. Resultados: Dos sete pacientes, seis (85,7%) sofreram queimadura unilateral e um (14,3%) sofreu queimadura bilateral. Cinco deles sofreram queimaduras por álcali (71,4%), um por ácido (14,3%) e um por pólvora de fogo de artifício (14,3%). A média de idade foi de 29,4 anos (±desvio-padrão de 13,3, intervalo de 14,0 a 47,0 anos). A acuidade visual média na primeira apresentação foi de 1,83±0,79 logMAR (0,015 decimal) e, após 1 ano de seguimento, foi de 0,85±0,70 logMAR (0,141 decimal). A acuidade visual melhorou significativamente, de 1,83±0,79 para 0,85±0,70 logMAR (p<0,05). Conclusão: O transplante de membrana amniótica é um tratamento adjuvante eficaz no manejo de queimaduras químicas da superfície ocular com potencial para melhorar a visão final.
Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Ophthalmologic Surgical Procedures/methods , Burns, Chemical/surgery , Eye Burns/surgery , Eye Burns/chemically induced , Cornea/surgery , Amnion/transplantation , Tissue Preservation , Visual Acuity , Prospective Studies , Membranes/transplantationABSTRACT
ABSTRACT Purpose: To evaluate the clinical results of cryopreserved amniotic membrane transplantation as a treatment option for refractory neurotrophic corneal ulcers. Methods: This prospective study included 11 eyes of 11 patients who underwent amniotic membrane transplantation for the treatment of refractory neurotrophic corneal ulcers at Hospital de Clínicas da Universidade Federal do Paraná, in the city of Curitiba, from May 2015 to July 2021. Patients underwent different surgical techniques in which the amniotic membrane was applied with the epithelium facing upward to promote corneal re-epithelialization. Results: The median age of the patients was 60 years (range, 34-82 years), and 64% were men. The predominant etiology of corneal ulcers was herpes zoster (45% of cases). Approximately one-third of the patients (27%) were chronically using hypotensive eye drops, and more than half (54%) had previously undergone penetrating corneal transplantation. At the time of amniotic membrane transplantation, 18% of the eyes had corneal melting, 9% had corneal perforation, and the others had corneal ulceration without other associated complications (73%). The time between clinical diagnosis and surgical treatment ranged from 9 days to 2 years. The corrected visual acuity was worse than 20/400 in 90% of the patients preoperatively, with improvement in 36% after 3 months of the procedure, worsening in 18% and remaining stable in 36%. Of the patients, 81% complained of preoperative pain, and 66% of them reported total symptom relief after the surgical procedure. In one month, 54.6% of the patients presented a closure of epithelial defect, and half of the total group evolved with corneal thinning. The failure rate was 45.5% of the cases. Conclusion: Cryopreserved amniotic membrane transplantation can be considered a good alternative for treating refractory neurotrophic corneal ulcers, as it resulted in significant improvement in pain (66%) and complete epithelial closure (60%) in many patients at 1 month postoperatively. Notably, the high failure rate highlights the need for further studies to identify patientand ulcer-related factors that may influence the outcomes of this procedure.
ABSTRACT
ABSTRACT Chlorpromazine is a medication widely used in psychiatry for the treatment of psychoses, especially schizophrenia. Since 1964, published articles have been correlating this medication with the appearance of ocular alterations. In this paper, we report the case of a 65-year-old patient with ocular effects due to long-term therapy with chlorpromazine. Biomicroscopy of both eyes presented diffuse granular brown deposits, most prominent at the deep stroma and corneal endothelium level. Also showed anterior subcapsular brown deposits with a stellate pattern in the lens. The total amount exceeds 2.000g (significant for the ocular alterations described) considering the patient's daily dosage of chlorpromazine of 300mg for ten years. After performing complete ophthalmic evaluation and discarding other causes for the ocular deposits, we diagnosed a secondary corneal deposit and cataract due to the use of chlorpromazine. This case reinforces the importance of periodic follow-up with an ophthalmologist for chlorpromazine users to trace ocular changes, heeding the exposure time and its dosage.
RESUMO A clorpromazina é uma medicação muito empregada na psiquiatria para tratamento de psicoses, especialmente em casos de esquizofrenia. Desde 1964 existem artigos publicados que correlacionam o uso dessa medicação com o aparecimento de alterações oculares. Neste trabalho, relatamos o caso de um paciente de 65 anos com efeitos oculares devido à terapia de longo prazo com clorpromazina. A biomicroscopia de ambos os olhos apresentou depósitos granulares difusos e de cor marrom, mais proeminente ao nível do estroma profundo e do endotélio da córnea, além de depósitos castanhos subcapsulares anteriores centrais em um padrão estrelado no cristalino. Considerando a dose diária de clorpromazina de 300mg por 10 anos usada pelo paciente, a quantidade total ultrapassa 2.000g (dose considerada significativa para as alterações oculares descritas). Após avaliação oftalmológica completa e descartado outras causas desses depósitos oculares, foram diagnosticados depósito corneano e catarata secundários ao uso de clorpromazina. O caso apresentado reforça a importância do acompanhamento oftalmolÓgico periÓdico de usuários de clorpromazina para o rastreio de alteraçÕes oculares, atentando-se ao tempo de exposição à droga e à posologia da mesma.
Subject(s)
Humans , Male , Aged , Cataract/chemically induced , Chlorpromazine/adverse effects , Chlorpromazine/toxicity , Cornea/drug effects , Corneal Diseases/chemically induced , Corneal Opacity/chemically induced , Pigmentation Disorders/chemically induced , Antipsychotic Agents/adverse effects , Antipsychotic Agents/toxicity , Antipsychotic Agents/therapeutic use , Bipolar Disorder/drug therapy , Visual Acuity , Chlorpromazine/administration & dosage , Chlorpromazine/therapeutic use , Corneal Diseases/diagnosis , Corneal Opacity/diagnosis , Slit Lamp , Slit Lamp MicroscopySubject(s)
Humans , Male , Female , Child , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Eye Injuries/surgery , Amnion/transplantation , Biological Dressings , Prospective Studies , Anterior Eye Segment/surgeryABSTRACT
PURPOSE: To describe a case of intracorneal epithelial cyst and present a surgical technique successfully used to treat this patient. METHODS: This interventional case report presents a 4-year-old boy with a progressive intrastromal corneal opacity and decreased vision in his right eye. The patient had no previous history of trauma or ocular surgery. After clinical examination and corneal optical coherence tomography, a presumptive diagnosis of a developmental epithelial cyst was made, and surgery was indicated. Four years later, when the patient was 8 year old, he returned after having performed drainage of the cyst in another service but still complaining of low vision. The biomicroscopy showed an intrastromal recurrent cyst. At this time, we recommended the surgical retreatment. The cyst was drained, a lamellar keratosclerectomy was performed at the site of the limbus where the epithelial nest was placed, and distilled water was used to wash the corneal cyst - to eliminate the epithelial cells. A donor cornea button was cut manually and was transplanted to cover the area where the corneoscleral tissue was removed. RESULTS: The surgical technique described resulted in nearly complete clearing of the opacity and improved vision, and no recurrence was documented up to 19 months of follow-up. The best-corrected visual acuity improved from 20/100 before surgery to 20/30 after surgery. CONCLUSIONS: This surgical technique may be a good alternative to other previously described treatments for intracorneal epithelial cysts aiming to avoid recurrence and without the need for central corneal transplantation.
Subject(s)
Corneal Diseases/surgery , Corneal Transplantation/methods , Cysts/surgery , Epithelium, Corneal/pathology , Tomography, Optical Coherence/methods , Child, Preschool , Corneal Diseases/diagnosis , Cysts/diagnosis , Humans , MaleABSTRACT
Abstract Objective: To evaluate the clinical effectiveness of amniotic membrane transplantation for ocular surface reconstruction. Methods: Prospective study including 23 eyes of 21 patients who underwent amniotic membrane transplantation at Hospital de Clínicas da Universidade Federal do Paraná (HC-UFPR) and at Cirurgia e Diagnose em Oftalmologia do Paraná (CDOP) clinic, located in Curitiba, PR, Brazil, from may 2015 to july 2019. The amniotic membrane was collected from elective and term cesarean delivery, and conserved in preservation medium and glycerol 1:1, stored at -80° Celsius. The membrane was fixed on the ocular surface with 10-0 nylon, 8-0 vicryl, biological glue or a combination of these materials. Results: The ocular surface reconstruction was successful in 22 eyes (95.6%). Failure was observed only in 1 case (bullous keratopathy) in which the condition was maintained postoperatively. Patients' age ranged from 11-82 years, with a mean age of 37.4 years. There was a higher incidence in males (66.6%). A difference was perceived in the distribution of the affected eye (which was greater in the right eye - 65.2%). As for the previous ophthalmic surgery history, 12 of the 23 eyes had a positive history (52.2%). It was observed that all patients who had preoperative visual acuity assessed showed improvement or maintenance of corrected visual acuity. In the postoperative period, complications associated with the underlying disease were observed, although not particularly related to the amniotic membrane transplantation. There were not any cases of postoperative infection. Conclusions: There was an improvement in the general state of the ocular surface in almost all of the cases in which the transplant was performed. Therefore, the amniotic membrane can be considered a good alternative for reconstructing the ocular surface, as a single or supporting treatment.
Resumo Objetivo: Avaliar a eficácia clínica do transplante de membrana amniótica na reconstrução da superfície ocular. Métodos: Estudo prospectivo incluiu 23 olhos de 21 pacientes que realizaram transplante de membrana amniótica no Hospital de Clínicas da Universidade Federal do Paraná (UFPR) e na clínica de Cirurgia e Diagnose em Oftalmologia do Paraná (CDOP), localizados em Curitiba, PR, Brasil, no período de maio de 2015 a julho de 2019. A membrana amniótica foi captada a partir de parto cesárea eletivo e a termo, conservada em meio de preservação e glicerol 1:1 e armazenada a -80° Celsius. A membrana foi fixada na superfície ocular com fio nylon 10-0 ou vicryl 8-0 e/ou cola biológica. Resultados: A idade dos pacientes variou de 11-82 anos, com média de 37,4 anos. Houve maior incidência no sexo masculino (66,6%). Ocorreu diferença na distribuição do olho acometido (maior no olho direito - 65,2%). Quanto à história de cirurgia oftalmológica prévia, 12 dos 23 olhos tinham história positiva (52,2%). Observamos que nos pacientes em que foi possível a avaliação da acuidade visual pré-operatória, todos apresentaram melhora ou manutenção da acuidade visual. No pós-operatório foi observado complicações associadas à doença de base e não propriamente ao transplante de membrana amniótica. Não foram registrados casos de infecção pós-operatória. Conclusão: Houve melhora do estado geral da superfície ocular em quase totalidade dos casos em que o transplante foi realizado. Portanto, a membrana amniótica pode ser considerada uma boa alternativa para reconstrução da superfície ocular, como tratamento único ou coadjuvante.
Subject(s)
Humans , Male , Female , Child , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Biological Dressings , Eye Injuries/surgery , Amnion/transplantation , Anterior Eye Segment/surgery , Prospective StudiesSubject(s)
Cornea/physiology , Keratoconus/physiopathology , Animals , Cornea/innervation , Humans , RabbitsABSTRACT
PURPOSE: To evaluate changes in corneal sensitivity after corneal collagen crosslinking in patients having progressive keratoconus. METHODS: Thirty-six consecutive patients having progressive keratoconus were included in the study. The crosslinking surgery was performed in one eye of each patient (study group) and the opposite eye was used as control (control group). The following steps were done in the procedure: central cornea epithelial debridement, riboflavin solution dropping (1 drop every 5 minutes) for 30 minutes, and subsequently, corneal surface irradiation with Ultraviolet A for 30 minutes, keeping the riboflavin instillation while irradiating. The analysis of corneal tactile sensitivity in each patient was performed using the Cochet-Bonnet aesthesiometer at 5 time points: preoperative and 7, 30, 90, and 180 days after surgery. RESULTS: The study enrolled 72 eyes of 36 patients. Considering the eyes submitted to crosslinking, there was a significant statistical difference concerning the tactile corneal sensitivity at all 5 evaluated moments. The median sensitivity at each time point studied was: preoperative, 52.5 mm (range, 25-60 mm); 7 days, 20.0 mm (range, 5-60 mm); 30 days, 32.5 mm (range, 5-60 mm); 90 days, 40.0 mm (range, 10-60 mm) and 180 days, 45.0 mm (range, 25-60 mm) (P < 0.001). The control group showed no statistical difference among all 5 time points (P = 0.160). CONCLUSIONS: Corneal crosslinking performed in keratoconus patients induced a considerable decrease in corneal sensitivity. This decrease was more intense at the first week after the procedure, with a progressive recovery up to 6 months.
Subject(s)
Cornea/physiopathology , Corneal Stroma/metabolism , Cross-Linking Reagents/therapeutic use , Hypesthesia/physiopathology , Keratoconus/drug therapy , Adolescent , Adult , Child , Collagen/metabolism , Cornea/metabolism , Diagnostic Techniques, Ophthalmological/instrumentation , Female , Humans , Hypesthesia/metabolism , Keratoconus/metabolism , Male , Photosensitizing Agents/therapeutic use , Prospective Studies , Riboflavin/therapeutic use , Ultraviolet Rays , Young AdultABSTRACT
PURPOSE: To evaluate the use of subconjunctival bevacizumab on corneal neovascularization in an experimental rabbit model for its effect on vessel extension, inflammation, and corneal epithelialization. METHODS: In this prospective, randomized, blinded, experimental study, 20 rabbits were submitted to a chemical trauma with sodium hydroxide and subsequently divided into two groups. The experimental group received a subconjunctival injection of bevacizumab (0.15 m; 3.75 mg), and the control group received an injection of 0.15 ml saline solution. After 14 days, two blinded digital photograph analyses were conducted to evaluate the inflammation/diameter of the vessels according to pre-established criteria. A histopathological analysis of the cornea evaluated the state of the epithelium and the number of polymorphonuclear cells. RESULTS: A concordance analysis using Kappa's statistic showed a satisfactory level of agreement between the two blinded digital photography analyses. The neovascular vessel length was greater in the control group (p<0.01) than in the study group. However, the histopathological examination revealed no statistically significant differences between the groups in terms of the state of the epithelium and the number of polymorphonuclear cells. CONCLUSIONS: Subconjunctival bevacizumab inhibited neovascularization in the rabbit cornea. However, this drug was not effective at reducing inflammation. The drug did not induce persistent corneal epithelial defects.
Subject(s)
Angiogenesis Inhibitors/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use , Corneal Neovascularization/drug therapy , Endothelium, Corneal/drug effects , Inflammation/drug therapy , Keratitis/drug therapy , Angiogenesis Inhibitors/administration & dosage , Animals , Antibodies, Monoclonal, Humanized/administration & dosage , Bevacizumab , Burns, Chemical/complications , Caustics , Corneal Neovascularization/etiology , Corneal Neovascularization/pathology , Disease Models, Animal , Endothelium, Corneal/growth & development , Eye Burns/complications , Injections, Intraocular , Keratitis/pathology , Male , Prospective Studies , Rabbits , Random Allocation , Severity of Illness Index , Sodium HydroxideABSTRACT
PURPOSE: To evaluate the use of subconjunctival bevacizumab on corneal neovascularization in an experimental rabbit model for its effect on vessel extension, inflammation, and corneal epithelialization. METHODS: In this prospective, randomized, blinded, experimental study, 20 rabbits were submitted to a chemical trauma with sodium hydroxide and subsequently divided into two groups. The experimental group received a subconjunctival injection of bevacizumab (0.15 m; 3.75 mg), and the control group received an injection of 0.15 ml saline solution. After 14 days, two blinded digital photograph analyses were conducted to evaluate the inflammation/diameter of the vessels according to pre-established criteria. A histopathological analysis of the cornea evaluated the state of the epithelium and the number of polymorphonuclear cells. RESULTS: A concordance analysis using Kappa's statistic showed a satisfactory level of agreement between the two blinded digital photography analyses. The neovascular vessel length was greater in the control group (p<0.01) than in the study group. However, the histopathological examination revealed no statistically significant differences between the groups in terms of the state of the epithelium and the number of polymorphonuclear cells. CONCLUSIONS: Subconjunctival bevacizumab inhibited neovascularization in the rabbit cornea. However, this drug was not effective at reducing inflammation. The drug did not induce persistent corneal epithelial defects.
Subject(s)
Animals , Male , Rabbits , Angiogenesis Inhibitors/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use , Corneal Neovascularization/drug therapy , Endothelium, Corneal/drug effects , Inflammation/drug therapy , Keratitis/drug therapy , Angiogenesis Inhibitors/administration & dosage , Antibodies, Monoclonal, Humanized/administration & dosage , Burns, Chemical/complications , Caustics , Corneal Neovascularization/etiology , Corneal Neovascularization/pathology , Disease Models, Animal , Endothelium, Corneal/growth & development , Eye Burns/complications , Injections, Intraocular , Keratitis/pathology , Prospective Studies , Random Allocation , Severity of Illness Index , Sodium HydroxideABSTRACT
OBJETIVO: Quantificar os potenciais doadores de córnea nas diferentes unidades hospitalares do Hospital de Clínicas da Universidade Federal do Paraná - UFPR. MÉTODOS: Foram analisados 369 prontuários de pacientes que foram a óbito nos meses de abril a julho de 2005 no HC-UFPR. No prontuário de cada paciente foram avaliados: evolução clínica, CID-10 e unidade hospitalar do óbito. Para ser considerado potencial doador (PD) utilizou-se como critérios de exclusão os tópicos citados no Manual de Transplantes (2ª edição - 2004) da Secretaria Estadual da Saúde do Estado do Paraná. Os PD foram agrupados em: data do óbito, tipo de internamento e unidade hospitalar. Analisamos a quantidade de PD e total de óbitos. RESULTADOS: Dos 369 prontuários analisados, foram considerados potenciais doadores (PD) 70 pacientes (18,97 por cento do total de prontuários analisados) As unidades: Centro de Terapia Intensiva, Centro de Terapia Semi e Pronto Atendimento Adulto foram responsáveis por 62,8 por cento dos PD. Já a Neurocirurgia, Emergência Cárdio e UTI Cirurgia Cardíaca apresentaram uma relação de PD por óbito superior a 60 por cento. CONCLUSÃO: Nesse estudo constatou-se que tanto as unidades com grande número de PD como aquelas com uma grande relação PD por óbito são locais de escolha para uma intervenção com o intuito de aumentar o número de doações em nosso meio.
PURPOSE: To quantify the potential cornea donor from the different units of Clinical Hospital of the UFPR. METHODS: 369 records of patients who died from april until july of 2005 in the HC-UFPR were analyzed. The medical records of each patient had been evaluated: the clinical evolution, CID-10 and hospital unit of the death. To be considered potential donor (PD) it was used as exclusion criteria the topics cited in the Manual of Transplants (2ª edition-2004) of the State Secretariat of the Health of the State of the Paraná. The PD had been grouped in: date of the death, type of internment and hospital unit. We analyze the amount of PD and total of deaths. RESULTS: Of 369 analyzed records, potential donor (PD) had been considered 70 patients (18.97 percent of the analyzed handbook total) the units: Center of Intensive Therapy, Center of Half Therapy and ER Adult had been responsible for 62,.8 percent of the PD. Already the neurosurgery, cardiac emergency and UTI cardiac surgery had presented a relation of PD per death superior than 60 percent. CONCLUSION: In this study we evidence that as much the units with great number of potential donor (PD) as those with a great relation PD per death are local of choice for an intervention with intention to increase the number of donations in our way.
ABSTRACT
PURPOSE: To evaluate the percentage of endothelial cell damage induced during a surgical technique of Descemet's membrane separation containing healthy endothelium, analyze the viability and efficacy of this technique, and evaluate the percentage of endothelial cell damage caused by inversion of the cornea on an artificial anterior chamber. METHODS: The corneas from three groups of 12 New Zealand rabbits were evaluated. The Group one was used as the control, so the corneas were analyzed after collected and trephinated. The Group two was analyzed after inversion of the cornea (endothelial side up at a convex shape) mounted on an artificial anterior chamber to calculate the percentage of endothelial cell damage caused by this inversion. The Group three was evaluated after the separation between the Descemet's membrane and the stroma using viscoelastic substance in corneas inverted and mounted on an artificial anterior chamber. The endothelial cell damage was analyzed by digital photographs taken under a microscope after staining the endothelium with alizarin red. Group three samples were processed for histologic evaluation. RESULTS: The Group three (viscoelastic separation) showed an index of endothelial cell damage of 10.06%, the Group two showed an index of 3.58% and the control group an index of 0.18% of endothelial cell damage (p<0.05). Histological evaluation of the Group three corneas revealed that approximately a 120 microm thickness of stroma remained attached to the Descemet's membrane. CONCLUSION: This technique should be better investigated because it is a viable and efficient alternative of Descemet's membrane separation for endothelial cells transplantation, since the percentage of induced cell damage is 10.06%. The percentage of endothelial cell damage caused by inversion of the cornea on an artificial anterior chamber was 3.58%.
Subject(s)
Cell Transplantation/methods , Descemet Membrane/surgery , Endothelium, Corneal/cytology , Endothelium, Corneal/transplantation , Animals , Corneal Transplantation , Descemet Membrane/cytology , Descemet Membrane/injuries , Male , Prospective Studies , Rabbits , Reproducibility of ResultsABSTRACT
OBJETIVO: Avaliar a porcentagem de dano endotelial induzido por uma técnica cirúrgica para a separação da membrana de Descemet contendo endotélio sadio, analisar a viabilidade e eficácia desta técnica, e avaliar a porcentagem de dano endotelial causado pela inversão da córnea em câmara anterior artificial. MÉTODOS: As córneas de três grupos de 12 coelhos da linhagem Nova Zelândia foram avaliadas. O grupo 1 foi usado como controle; portanto, as córneas foram analisadas após coletadas e trepanadas. O grupo 2 foi analisado após a inversão da córnea (endotélio para cima na posição convexa), montada em câmara anterior artificial, para o cálculo da porcentagem do dano endotelial induzido por esta inversão. O grupo 3 foi avaliado após a separação entre a membrana de Descemet e o estroma com o uso de substância viscoelástica em córneas invertidas e montadas em câmara anterior artificial. O dano endotelial foi avaliado por meio de fotografias digitais tiradas no microscópio após impregnar o endotélio com vermelho de alizarina. Amostras do grupo 3 foram processadas para avaliação histopatológica. RESULTADOS: O grupo 3 (separação viscoelástica) apresentou um índice de lesão celular endotelial de 10,06 por cento, o grupo 2 apresentou um índice de 3,58 por cento e o grupo controle um índice de 0,18 por cento de lesão celular endotelial (p<0,05). A avaliação histológica das córneas do grupo 3 revelou que aproximadamente 120 µm de espessura estromal manteve-se aderido à membrana de Descemet. CONCLUSÃO: Esta técnica deve ser melhor investigada, pois é uma alternativa viável e eficaz de separação da membrana de Descemet para transplante celular endotelial, já que o porcentual de dano celular induzido é de 10,06 por cento. A porcentagem de dano celular causado pela inversão da córnea em câmara anterior artificial foi de 3,58 por cento.
PURPOSE: To evaluate the percentage of endothelial cell damage induced during a surgical technique of Descemet's membrane separation containing healthy endothelium, analyze the viability and efficacy of this technique, and evaluate the percentage of endothelial cell damage caused by inversion of the cornea on an artificial anterior chamber. METHODS: The corneas from three groups of 12 New Zealand rabbits were evaluated. The Group one was used as the control, so the corneas were analyzed after collected and trephinated. The Group two was analyzed after inversion of the cornea (endothelial side up at a convex shape) mounted on an artificial anterior chamber to calculate the percentage of endothelial cell damage caused by this inversion. The Group three was evaluated after the separation between the Descemet's membrane and the stroma using viscoelastic substance in corneas inverted and mounted on an artificial anterior chamber. The endothelial cell damage was analyzed by digital photographs taken under a microscope after staining the endothelium with alizarin red. Group three samples were processed for histologic evaluation. RESULTS: The Group three (viscoelastic separation) showed an index of endothelial cell damage of 10.06 percent, the Group two showed an index of 3.58 percent and the control group an index of 0.18 percent of endothelial cell damage (p<0.05). Histological evaluation of the Group three corneas revealed that approximately a 120 µm thickness of stroma remained attached to the Descemet's membrane. CONCLUSION: This technique should be better investigated because it is a viable and efficient alternative of Descemet's membrane separation for endothelial cells transplantation, since the percentage of induced cell damage is 10.06 percent. The percentage of endothelial cell damage caused by inversion of the cornea on an artificial anterior chamber was 3.58 percent.
Subject(s)
Animals , Male , Rabbits , Cell Transplantation/methods , Descemet Membrane/surgery , Endothelium, Corneal/cytology , Endothelium, Corneal/transplantation , Corneal Transplantation , Descemet Membrane/cytology , Descemet Membrane/injuries , Prospective Studies , Reproducibility of ResultsABSTRACT
PURPOSE: To analyze the quality of the corneas evaluated by slit lamp examination in the Eye Bank of the Hospital de Clínicas UFPR and its relation to donor age and cause of death. METHODS: Analysis of 492 corneas, evaluated in BTO HC-UFPR between August 2006 to August 2008. Each cornea was classified regarding the quality as: very good, good, regular and bad; and according to clarity, epithelial defect, stromal edema, Descemet's folds, stromal opacity, corneal scarring, endothelial density and guttata. RESULTS: The mean donor age was 42.74 years (sd=17.77 years). Among the causes of death, trauma was the most common with 46.18%, followed by cardiovascular causes with 41.86%. In relation to the cornea, 57.11% were classified as 'good', followed by 20.73% as 'regular', 16.87% as 'very good' and 5.28% as 'bad'. With the application of statistical tests based on ordinal regression model, trauma deaths corneas tend to be better, as well as those of younger patients. CONCLUSIONS: Statistically, the corneas from younger donors tend to have better graduations in the assessment, as well as the corneas from donors dead by trauma that tend to have better quality when compared to corneas from donors dead by cardiovascular and other systemic diseases.
Subject(s)
Cause of Death , Cornea/anatomy & histology , Tissue Donors/statistics & numerical data , Adolescent , Adult , Age Distribution , Age Factors , Aged , Aged, 80 and over , Child , Cornea/physiology , Humans , Middle Aged , Quality Control , Regression Analysis , Retrospective Studies , Young AdultABSTRACT
OBJETIVO: Analisar a qualidade das córneas avaliadas em lâmpada de fenda no Banco de Tecidos Oculares do Hospital de Clínicas da Universidade Federal do Paraná (BTO HC-UFPR) relacionando com a idade e causa de óbito. MÉTODOS: Foram analisadas retrospectivamente fichas de avaliações padronizadas de 492 córneas, avaliadas no BTO HC-UFPR, do período de agosto de 2006 a agosto de 2008. Cada córnea avaliada foi classificada em relação a sua qualidade em: Muito bom, bom, regular e ruim; mediante os seguintes fatores: claridade da córnea, edema epitelial, defeito epitelial, edema estromal, dobras de Descemet, opacidade estromal, cicatrizes corneanas, densidade endotelial e guttata. RESULTADOS: A idade média dos doadores foi de 42,74 anos (dp=17,77). Dentre as causas de óbito, a mais comum foi trauma com 46,18 por cento, seguindo por causas cardiovasculares com 41,86 por cento. Na avaliação da córnea, foram classificadas: 57,11 por cento como "bom", seguido por 20,73 por cento "regular", 16,87 por cento "muito bom" e 5,28 por cento "ruim". Com aplicação de testes estatísticos baseados em modelo de regressão ordinal verificou-se que as córneas provenientes de mortes por traumas tendem a ser melhores, bem como aquelas de pacientes mais jovens. CONCLUSÕES: Estatisticamente, córneas de doadores mais jovens tendem a ter melhores graduações na avaliação, bem como córneas provenientes de doadores com morte por trauma tendem a ser de melhor qualidade quando comparadas com as provenientes de mortes por doenças cardiovasculares e outras doenças sistêmicas.
PURPOSE: To analyze the quality of the corneas evaluated by slit lamp examination in the Eye Bank of the Hospital de Clínicas UFPR and its relation to donor age and cause of death. METHODS: Analysis of 492 corneas, evaluated in BTO HC-UFPR between August 2006 to August 2008. Each cornea was classified regarding the quality as: very good, good, regular and bad; and according to clarity, epithelial defect, stromal edema, Descemet's folds, stromal opacity, corneal scarring, endothelial density and guttata. RESULTS: The mean donor age was 42.74 years (sd=17.77 years). Among the causes of death, trauma was the most common with 46.18 percent, followed by cardiovascular causes with 41.86 percent. In relation to the cornea, 57.11 percent were classified as "good", followed by 20.73 percent as "regular", 16.87 percent as "very good" and 5.28 percent as "bad". With the application of statistical tests based on ordinal regression model, trauma deaths corneas tend to be better, as well as those of younger patients. CONCLUSIONS: Statistically, the corneas from younger donors tend to have better graduations in the assessment, as well as the corneas from donors dead by trauma that tend to have better quality when compared to corneas from donors dead by cardiovascular and other systemic diseases.
Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Child , Humans , Middle Aged , Young Adult , Cause of Death , Cornea/anatomy & histology , Tissue Donors/statistics & numerical data , Age Distribution , Age Factors , Cornea/physiology , Quality Control , Regression Analysis , Retrospective Studies , Young AdultABSTRACT
PURPOSE: The purpose of this study was to compare total testosterone blood level among three groups of postmenopausal women: control, mild to moderate dry eye and severe dry eye. METHODS: Twenty-nine postmenopausal women were selected. The exclusion criteria were: hormone replacement therapy in the last 8 weeks, mechanical palpebral abnormalities, pterygium, lacrimal obstructions, intraocular inflammation or contact lens use. A blood sample was collected for total testosterone level determination, and the patients were submitted to an ophthalmologic examination (emphasizing on dry eye detection) and answered the OSDI (Ocular Surface Disease Index) questionnaire. Five patients were excluded. Postmenopausal women were divided into three groups according to OSDI score and the ophthalmic examination. RESULTS: Five patients were classified in the no dry eye group (control), fifteen in the mild to moderate dry eye group and four in the severe dry eye group. There were no statistically significant differences regarding mean age (p=0.3915); instruction level (p=0.9333); number of comorbidities (p=0.2551); medication taken (p=0.2844) and total testosterone level among those groups (p=0.1275). CONCLUSION: Further research with a greater bigger sample is necessary to establish the relation of androgen levels in dry eye patients.
Subject(s)
Dry Eye Syndromes/blood , Postmenopause/blood , Testosterone/blood , Cross-Sectional Studies , Female , Humans , Middle Aged , Severity of Illness Index , Surveys and QuestionnairesABSTRACT
OBJETIVO: Comparar o nível sérico de testosterona total entre mulheres pós-menopausa divididas em 3 grupos: controle, olho seco leve a moderado e olho seco intenso. MÉTODOS: No ambulatório de climatério foram selecionadas 29 mulheres pós-menopausa que não faziam reposição hormonal há pelo menos 8 semanas. Critérios de exclusão: alterações palpebrais mecânicas, pterígio, obstrução de vias lacrimais, inflamação intra-ocular e uso de lente de contato. As mulheres selecionadas foram submetidas à dosagem de testosterona total, aplicação do questionário OSDI (Ocular Surface Disease Index) e exame oftalmológico para detecção de olho seco. As mulheres foram divididas em 3 grupos conforme o resultado do escore OSDI e do exame oftalmológico. RESULTADOS: Cinco pacientes foram classificadas como ausência de olho seco, 15 com olho seco leve a moderado e 4 com olho seco intenso. Não houve diferença estatisticamente significativa entre a média dos valores das idades (p=0,3915); nível de instrução (p=0,9333); doenças associadas (p=0,2551); tipo de medicação utilizada (p=0,2844) e nível sérico de testosterona total entre os grupos (p=0,1275). CONCLUSÃO: Não encontramos diferença estatisticamente significativa entre o nível de testosterona total entre mulheres pós-menopausa com olho seco. Novos estudos clínicos com maior amostra são necessários para melhor esclarecer a relação dos níveis séricos dos androgênios nos portadores de olho seco.
PURPOSE: The purpose of this study was to compare total testosterone blood level among three groups of postmenopausal women: control, mild to moderate dry eye and severe dry eye. METHODS: Twenty-nine postmenopausal women were selected. The exclusion criteria were: hormone replacement therapy in the last 8 weeks, mechanical palpebral abnormalities, pterygium, lacrimal obstructions, intraocular inflammation or contact lens use. A blood sample was collected for total testosterone level determination, and the patients were submitted to an ophthalmologic examination (emphasizing on dry eye detection) and answered the OSDI (Ocular Surface Disease Index) questionnaire. Five patients were excluded. Postmenopausal women were divided into three groups according to OSDI score and the ophthalmic examination. RESULTS: Five patients were classified in the no dry eye group (control), fifteen in the mild to moderate dry eye group and four in the severe dry eye group. There were no statistically significant differences regarding mean age (p=0.3915); instruction level (p=0.9333); number of comorbidities (p=0.2551); medication taken (p=0.2844) and total testosterone level among those groups (p=0.1275). CONCLUSION: Further research with a greater bigger sample is necessary to establish the relation of androgen levels in dry eye patients.
Subject(s)
Female , Humans , Middle Aged , Dry Eye Syndromes/blood , Postmenopause/blood , Testosterone/blood , Cross-Sectional Studies , Severity of Illness Index , Surveys and QuestionnairesABSTRACT
PURPOSE: Replacing diseased corneal endothelium with a preparation of Descemet membrane carrying functional endothelium and no stroma may be a feasible method for treating corneal endothelial decompensation. To obtain a viable donor of a Descemet membrane endothelium disc, we modified the Descemet membrane stripping technique and monitored the percentage of endothelial damage to the donor tissue preparation. METHODS: Forty-eight human corneas were used. Cornea buttons were mounted on an artificial anterior chamber, endothelial side up. Endothelia were stained with alizarin red, examined under the microscope, and photographed at 5 different sites (microscope, x100; digital magnification, x2.83). A 6 x 7-mm rectangular piece of endothelium-Descemet membrane complex was obtained using a Grieshaber microsurgical knife and Kelman-McPherson forceps. Digital photographs of endothelia were analyzed with a computer, and the percentage of endothelial damage was calculated. Specimens were processed for hematoxylin-eosin staining. RESULTS: Forty of 48 endothelium-Descemet membrane preparations (83.3%) were complete peels with minimal endothelial damage. Endothelial damage before and after the surgery was 1.57 +/- 2.11% and 2.61 +/- 1.77%, respectively. Eight preparations (16.7%) failed because of tearing. Multiple hematoxylin-eosin-stained sections showed the presence of endothelium with intact Descemet membrane and no stromal tissue. CONCLUSION: We modified the technique of Melles and obtained a sheet of Descemet membrane and endothelium with minimal endothelial damage and with no remaining stroma observed. This simple technique can be used to obtain the endothelium-Descemet membrane complex in minutes. It may be useful for corneal endothelium transplantation.